Literature DB >> 27608827

Fasciolosis in South America: epidemiology and control challenges.

C Carmona1, J F Tort2.   

Abstract

Fasciolosis caused by Fasciola hepatica severely affects the efficiency of livestock production systems worldwide. In addition to the economic impact inflicted on livestock farmers, fasciolosis is an emergent zoonosis. This review emphasizes different aspects of the disease in South America. Available data on epidemiology in bovines and ovines in different countries, as well as a growing body of information on other domestic and wildlife definitive hosts, are summarized. The issue of drug resistance that compromises the long-term sustainability of current pharmacological strategies is examined from a regional perspective. Finally, efforts to develop a single-antigen recombinant vaccine in ruminants are reviewed, focusing on the cases of leucine aminopeptidase or thioredoxin glutathione reductase.

Entities:  

Mesh:

Year:  2016        PMID: 27608827     DOI: 10.1017/S0022149X16000560

Source DB:  PubMed          Journal:  J Helminthol        ISSN: 0022-149X            Impact factor:   2.170


  9 in total

1.  Liver Fluke Vaccine Assessment in Cattle.

Authors:  Gabriela Maggioli; Cecilia Salazar; Federico Fossa; Carlos Carmona
Journal:  Methods Mol Biol       Date:  2020

2.  Pleiotropic alterations in gene expression in Latin American Fasciola hepatica isolates with different susceptibility to drugs.

Authors:  Santiago Radio; Santiago Fontenla; Victoria Solana; Anna C Matos Salim; Flávio Marcos Gomes Araújo; Pedro Ortiz; Cristian Hoban; Estefan Miranda; Valeria Gayo; Fabiano Sviatopolk-Mirsky Pais; Hugo Solana; Guilherme Oliveira; Pablo Smircich; José F Tort
Journal:  Parasit Vectors       Date:  2018-01-24       Impact factor: 3.876

3.  Infection by the Helminth Parasite Fasciola hepatica Requires Rapid Regulation of Metabolic, Virulence, and Invasive Factors to Adjust to Its Mammalian Host.

Authors:  Krystyna Cwiklinski; Heather Jewhurst; Paul McVeigh; Tara Barbour; Aaron G Maule; Jose Tort; Sandra M O'Neill; Mark W Robinson; Sheila Donnelly; John P Dalton
Journal:  Mol Cell Proteomics       Date:  2018-01-10       Impact factor: 5.911

4.  Fasciola gigantica-Derived Excretory-Secretory Products Alter the Expression of mRNAs, miRNAs, lncRNAs, and circRNAs Involved in the Immune Response and Metabolism in Goat Peripheral Blood Mononuclear Cells.

Authors:  Sha-Sha Wang; Dan Chen; Jun-Jun He; Wen-Bin Zheng; Ai-Ling Tian; Guang-Hui Zhao; Hany M Elsheikha; Xing-Quan Zhu
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

Review 5.  Human Fascioliasis: Current Epidemiological Status and Strategies for Diagnosis, Treatment, and Control.

Authors:  Maria Alejandra Caravedo; Miguel Mauricio Cabada
Journal:  Res Rep Trop Med       Date:  2020-11-26

6.  Stunting in pre-school and school-age children in the Peruvian highlands and its association with Fasciola infection and demographic factors.

Authors:  Camille M Webb; Maria Luisa Morales; Martha Lopez; Benicia Baca-Turpo; Eulogia Arque; A Clinton White; Miguel M Cabada
Journal:  PLoS Negl Trop Dis       Date:  2021-06-21

7.  Comparison of Liver Condemnation and Bile Microscopy As Tools to Estimate Fasciola hepatica Prevalence and Burden in the Anta Province of Cusco in Peru.

Authors:  Maria Alejandra Caravedo; A Clinton White; Maria Luisa Morales; Martha Lopez; Melinda Barbara Tanabe; Benicia Baca-Turpo; Eulogia Arque; Daniela Madrid; Prithvi Vallabh; Ruben Bascope; Miguel Mauricio Cabada
Journal:  Vector Borne Zoonotic Dis       Date:  2021-06-14       Impact factor: 2.523

Review 8.  Drug resistance in liver flukes.

Authors:  I Fairweather; G P Brennan; R E B Hanna; M W Robinson; P J Skuce
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2020-01-10       Impact factor: 4.077

9.  A Vaccine Based on Kunitz-Type Molecule Confers Protection Against Fasciola hepatica Challenge by Inducing IFN-γ and Antibody Immune Responses Through IL-17A Production.

Authors:  Leonardo Silvane; Daiana Pamela Celias; Pablo Alberto Romagnoli; Belkys Angélica Maletto; María Fernanda Sanchez Vallecillo; Laura Silvina Chiapello; Santiago Daniel Palma; Daniel Alberto Allemandi; Rodrigo Eduardo Fabrizio Sanabria; César Iván Pruzzo; Claudia Cristina Motrán; Laura Cervi
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.